Emodin prevents renal ischemia-reperfusion injury via suppression of CAMKII/DRP1-mediated mitochondrial fission
Introduction
Acute kidney injury (AKI) is an essential contributor to the development of chronic kidney disease (CKD) (Chawla et al., 2014), characterized by the accumulation of end products of nitrogen metabolism (urea and creatinine) and the rapid loss of renal function. Ischemia and reperfusion (I/R) injury can occur after surgical procedures. It is one of the most common causes of AKI and associated with substantial mortality and morbidity(Cao et al., 2017). However, there are currently no effective therapeutic strategies for the treatment of AKI after I/R injury.
Accumulating evidence indicates that mitochondria play a vital role in the progression of AKI. The proximal renal tubule is dilated, and the brush border is lost in clinical biopsies of AKI. Renal proximal tubule cells also exhibit mitochondrial dysfunction(Basile et al., 2012;Linkermann et al., 2014). Mitochondrial dynamics are disrupted, thereby contributing to mitochondrial fragmentation(Andrade−Oliveira et al., 2015). Fragmented mitochondria are potential sources of reactive oxygen species (ROS), cytochrome C, mitochondrial DNA, and other potentially injurious molecules(Emma et al., 2016) that can induce tubular cell death(Yang et al., 2016). Therefore, mitochondria might be a therapeutic target for AKI(Emma et al., 2016). Studies revealed that stimulated mitochondrial biogenesis reduced necrosis and improved renal function in mice that were subjected to I/R-induced AKI(Jesinkey et al., 2014). The inhibition of mitochondrial fission conferred significant protection against I/R-induced AKI(Brooks et al., 2009). Therefore, the early protection of mitochondrial function may be a therapeutic alternative to suppress oxidative stress and inflammation and prevent tubular necrosis(Szeto et al., 2011).
Emodin (1,3,8-trihydroxy-6-methylanthraquinone) is an anthraquinone derivative from the rhizome of Rheum palmatum L. It is the main active monomer of Da Huang (Radix et Rhizoma Rhei) (Liu et al., 2015). Emerging evidence indicates that emodin has a wide range of pharmacological properties, such as antibacterial(Li et al., 2016), anti-inflammatory(Xia et al., 2019), antioxidant(Xia et al., 2019), immunosuppressive(Qiu et al., 2017), and anti-renal fibrosis(Ma et al., 2018) effects. Accumulating evidence shows that emodin inhibits abnormal intrinsic renal changes and plays a role in protecting the kidneys. A randomized clinical trial reported that emodin decreased the gluconeogenesis of renal tubular cells and decreased adenosine triphosphate (ATP) content in epithelial mitochondria(Khan et al., 2014). Another study found that emodin reduced the activity of Na+/K+-ATPase and Ca2+-ATPase in epithelial cells(Zhou and Chen, 1988). Emodin was also reported to prevent H/R-induced apoptosis in human renal tubular cells along with the restoration of the Bcl-2/Bax ratio(Chen et al., 2017). However, the effect of emodin on renal I/R injury has not been well documented.
Therefore, the present study investigated whether emodin protected against renal I/R injury and explored the underlying mechanisms. Our results showed that emodin exerted renoprotective effects by restoring the dynamic balance of mitochondrial fusion and fission, maintaining mitochondrial homeostasis, and reducing tubular cell death by inhibiting the activity of calcium/calmodulin-dependent protein kinase II (CAMKII) and downregulating the phosphorylation of dynamin-related protein 1 (DRP1) at Ser616.
Section snippets
Reagents
HK2 (human kidney proximal tubular cells) cells were purchased from Cell Culture Centre, Institute of Basic Medical Science Chinese Academy of Medical Sciences (Beijing, China). Emodin was purchased from Shanghai Yuanye Bio-Technology (Shanghai, China). DRP1 antibody, phospho-DRP1 (Ser616) antibody, phospho-DRP1 (Ser637) antibody, MFN2 antibody, OPA1 antibody, PINK1 antibody, PARKIN antibody, CASPASE-3 antibody, Cleaved CASPASE-3 antibody, BAX antibody, BCL2 antibody were purchased from Cell
Emodin ameliorated functional and histological I/R-induced renal injury
To investigate the effects of emodin on I/R-induced AKI, it was injected intraperitoneally at doses of 1, 3, 10 mg/kg for 7 days before renal I/R surgery. In mice with I/R injury, serum creatinine concentrations, and urea nitrogen (BUN) levels were elevated. Pretreatment with 1, 3, and 10 mg/kg emodin dose-dependently decreased serum creatinine and BUN levels (Fig. 1A and B). KIM-1, a biomarker of renal injury, was upregulated in the I/R group, and significantly downregulated in the
Discussion
The present study found that emodin ameliorated I/R-induced renal injury by regulating mitochondrial homeostasis in renal tubular epithelial cells. Emodin prevented I/R-induced renal injury and protected renal tubular epithelial cells from I/R-induced apoptosis. Emodin also restored the dynamic balance of mitochondrial fusion and fission and maintained mitochondrial homeostasis in renal tubular epithelial cells. Furthermore, emodin downregulated the phosphorylation of DRP1 at Ser616 in a
CRediT authorship contribution statement
Yanqing Wang: Investigation, Data curation, Writing – original draft. Qian Liu: Investigation, Data curation, Writing – original draft, Writing – review & editing, Visualization. Jiaying Cai: Investigation, Data curation, Visualization. Pin Wu: Investigation, Data curation. Di Wang: Investigation, Data curation. Yundi Shi: Investigation, Data curation. Tianru Huyan: Investigation, Data curation, Writing – original draft. Jing Su: Investigation, Resources, Funding acquisition. Xuejun Li:
Declaration of competing interest
The authors declare that they have no competing interests.
Acknowledgement
This work was supported by the National Natural Science Foundation of China (No. 81974506, 81673486, 81373405 and 30901803 to L. T., No. 81802245 to J. S., No. 81874318, 82073878 and 81673453 to X.-J. L.), the Beijing Natural Science Foundation (No. Z200019 and 7172119), and the Interdisciplinary Medicine Seed Fund of Peking University (BMU2020MX032).
References (51)
- et al.
Emodin attenuates TNF-alpha-induced apoptosis and autophagy in mouse C2C12 myoblasts though the phosphorylation of Akt
Int. Immunopharm.
(2016) - et al.
Erk2 phosphorylation of Drp1 promotes mitochondrial fission and MAPK-driven tumor growth
Mol Cell
(2015) - et al.
Mst1 deletion attenuates renal ischaemia-reperfusion injury: the role of microtubule cytoskeleton dynamics, mitochondrial fission and the GSK3beta-p53 signalling pathway
Redox Biol
(2019) - et al.
The antibacterial activity and action mechanism of emodin from Polygonum cuspidatum against Haemophilus parasuis in vitro
Microbiol. Res.
(2016) - et al.
Emodin attenuates apoptosis and inflammation induced by LPS through up-regulating lncRNA TUG1 in murine chondrogenic ATDC5 cells
Biomed. Pharmacother.
(2018) - et al.
FOXO1 inhibition potentiates endothelial angiogenic functions in diabetes via suppression of ROCK1/Drp1-mediated mitochondrial fission
Biochim. Biophys. Acta (BBA) - Mol. Basis Dis.
(2018) - et al.
Fundc1-dependent mitophagy is obligatory to ischemic preconditioning-conferred renoprotection in ischemic AKI via suppression of Drp1-mediated mitochondrial fission
Redox Biol
(2020) - et al.
Renoprotective approaches and strategies in acute kidney injury
Pharmacol. Ther.
(2016) - et al.
Aloe-emodin attenuates myocardial infarction and apoptosis via up-regulating miR-133 expression
Pharmacol. Res.
(2019) - et al.
Microcystin-leucine-arginine induced neurotoxicity by initiating mitochondrial fission in hippocampal neurons
Sci. Total Environ.
(2020)
Empagliflozin rescues diabetic myocardial microvascular injury via AMPK-mediated inhibition of mitochondrial fission
Redox Biol
Gut bacteria products prevent AKI induced by ischemia-reperfusion
J. Am. Soc. Nephrol.
Mitochondrial dynamics--mitochondrial fission and fusion in human diseases
N. Engl. J. Med.
The role of Drp1 adaptor proteins MiD49 and MiD51 in mitochondrial fission: implications for human disease
Clin. Sci. (Lond.)
Pathophysiology of acute kidney injury
Comp. Physiol.
Mitochondrial energetics in the kidney
Nat. Rev. Nephrol.
CaMKII as a pathological mediator of ER stress, oxidative stress, and mitochondrial dysfunction in a murine model of nephronophthisis
Am. J. Physiol. Ren. Physiol.
Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models
J. Clin. Invest.
Gamma irradiation of aloe-emodin induced structural modification and apoptosis through a ROS- and caspase-dependent mitochondrial pathway in stomach tumor cells
Int. J. Radiat. Biol.
Reno-cerebral reflex activates the renin-angiotensin system, promoting oxidative stress and renal damage after ischemia-reperfusion injury
Antioxidants Redox Signal.
Acute kidney injury and chronic kidney disease as interconnected syndromes
N. Engl. J. Med.
Emodin protects against oxidative stress and apoptosis in HK-2 renal tubular epithelial cells after hypoxia/reoxygenation
Exp Ther Med
Mitochondrial dysfunction in inherited renal disease and acute kidney injury
Nat. Rev. Nephrol.
CoCl2 induces apoptosis via a ROS-dependent pathway and Drp1-mediated mitochondria fission in periodontal ligament stem cells
Am. J. Physiol. Cell Physiol.
Mitochondria: a therapeutic target in acute kidney injury
Nephrol. Dial. Transplant.
Cited by (0)
- 1
These authors contributed equally to this work.